Heart Disease Trials
Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.
Page 1 of 1 | Results 1 - 8 of 8
Heart,
Surgery
Baystate Medical Center, 759 Chestnut St, Springfield, MA
The purpose of this study is to demonstrate that Fractional Flow Reserve (FFR)-guided Percutaneous Coronary Intervention (PCI) is non-inferior to coronary artery bypass graft surgery (CABG) in patients with multi-vessel Coronary Artery Disease (CAD). FFF-guided PCI might result in lower rates of death, heart attack, and the need for repeat revascularization as compared to what was seen after CABG surgery. There is also the possibility of a chance at a shorter recovery time with the minimally invasive FFR-guided PCI versus CABG surgery.
Heart
Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199
Heart
Baystate Medical Center, 759 Chestnut Street, Springfield, MA
Heart
Baystate Medical Center, 759 Chestnut Street, Springfield, MA
Heart
Baystate Medical Center, 759 Chestnut St, Springfield, MA
The purpose of this study is to test the efficacy of 4 mg Pitavastatin daily on cardiovascular-related events among HIV-1 infected adults.
HIV,
Heart
Baystate Infectious Diseases Clinical Research, 3300 Main Street, Springfield, MA 01199
Heart,
Surgery
Baystate Medical Center, 759 Chestnut St, Springfield, MA
The purpose of this study is to demonstrate that the safety and effectiveness of the Medtronic Transcatheter Aortic Valve Replacement (TAVR) system as measured by rates of all-cause mortality or disabling stroke at two years is non-inferior to Surgical Aortic Valve Replacement (SAVR) in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.
Heart
Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199
Page 1 of 1 | Results 1 - 8 of 8
We use cookies and other tools to improve your website experience and to analyze how visitors use our website. For more information, please see our Privacy Policy.